BioPharmX Corporation (OTCQB: BPMX) filed its form 8-A registration statement in connection with changing the listing of the common stock from the OTCQB to the NYSE MKT. The quotation of the common stock on the OTCQB is scheduled to be terminated following the closing of trading on June 10, 2015, with the listing of the common stock on the NYSE MKT begining at the opening of trading on June 11, 2015 and remain under the symbol "BPMX."